Concepedia

Author

Masaaki Ogasa

Sunovion (United States)

Also Known As

M. Ogasa, Masaaki Ogasa

28

Publications

1.2K

Citations

7

H-Index

12

Concepts

All Affiliations

Sunovion (United States)Kanazawa UniversityVion Pharmaceuticals (United States)Sumitomo Dainippon Pharma (Japan)University of Miami
MO

About

Masaaki Ogasa is an author at Sunovion (United States) specializing in social sciences, psychiatry, and clinical psychiatry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Social Sciences

2

2

149

2

Medicine

1

1

54

3

Cognitive Science

1

1

95

4

Psychiatry

1

1

54

5

Psychology

1

1

95

Masaaki Ogasa

×

7

Publications

1.2K

Citations

7

H-Index

YearCitations

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Kumiko Tokuda,

Journal of Pharmacology and Experimental Therapeutics

2010

422

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

Herbert Y. Meltzer, Josephine Cucchiaro, Robert Silva,

American Journal of Psychiatry

2011

248

Lurasidone in the Treatment of Acute Schizophrenia

Mitsutaka Nakamura, Masaaki Ogasa, John Guarino,

The Journal of Clinical Psychiatry

2009

192

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

Masaaki Ogasa, Tatsuya Kimura, Mitsutaka Nakamura,

Psychopharmacology

2012

116

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

Philip D. Harvey, Masaaki Ogasa, Josephine Cucchiaro,

Schizophrenia Research

2011

95

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

Steven G. Potkin, Masaaki Ogasa, Josephine Cucchiaro,

Schizophrenia Research

2011

54

Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study

Philip D. Harvey, Cynthia Siu, Masaaki Ogasa,

Schizophrenia Research

2015

31

Page 1